Mayne Pharma Inc recalls Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufac
Recalled June 29, 2022 · FDA recall D-1152-2022 · Mayne Pharma
Hazard
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint. · FDA Class II
Units
1440 cartons
Sold at
Nationwide in the US Market
Description
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
Product
Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834
Manufacturer(s)
Mayne Pharma Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →